Trial Profile
Efficacy of combination of denosumab and alfacalcidol in patients with postmenopausal osteoporosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 May 2015
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Denosumab (Primary) ; Alfacalcidol; Calcium
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 29 Mar 2015 Results presented at the 2015 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
- 26 Dec 2014 New trial record